The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus

Table 2

Glucose-lowering medication in patients of COVID-19 with T2DM.

Glucose-lowering medication	Case (%)
Metformin	12 (16.90%)
Insulin	7 (9.86%)
Acarbose	6 (8.45%)
SGLT2-I	2 (2.82%)
Pioglitazone	1 (1.41%)

SGLT2: sodium-dependent glucose transporters 2 inhibitors.